Gao B, Gao W, Wan H, Xu F, et al. Efficacy and safety of alogliptin versus acarbose in Chinese type 2 diabetes patients with high cardiovascular risk or coronary heart disease treated with aspirin, and inadequately controlled with metformin monotherapy or drug naive: a multicenter, ra Diabetes Obes Metab 2022 Feb 3. doi: 10.1111/dom.14661.
PMID: 35112779